Ana Martin-Lopez

Leganes, MD, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

Evaluation of the exposure-response relationship of pembrolizumab in non-small cell lung cancer: observational study protocol in real-world clinical practice.

Evaluation of the exposure-response relationship of pembrolizumab in non-small cell lung cancer: observational study protocol in real-world clinical practice.

Journal: BMC cancer
Published: January 29, 2026

Early pembrolizumab plasma levels as a prognostic biomarker in real-world NSCLC patients.

Early pembrolizumab plasma levels as a prognostic biomarker in real-world NSCLC patients.

Journal: Pharmacological research
Published: December 02, 2025

Real-World Data of First-Line Cemiplimab Monotherapy for Metastatic Non-Small Cell Lung Cancer (NSCLC) with PD-L1 Expression ≥ 50%: A National Spanish Multicentric Cohort (CEMI-SPA Study).

Real-World Data of First-Line Cemiplimab Monotherapy for Metastatic Non-Small Cell Lung Cancer (NSCLC) with PD-L1 Expression ≥ 50%: A National Spanish Multicentric Cohort (CEMI-SPA Study).

Journal: Cancers
Published: September 21, 2025

Induction chemo-immunotherapy followed by chemo-radiotherapy and immunotherapy maintenance in stage III NSCLC (APOLO): a phase 2 trial.

Induction chemo-immunotherapy followed by chemo-radiotherapy and immunotherapy maintenance in stage III NSCLC (APOLO): a phase 2 trial.

Journal: Nature communications
Published: May 23, 2025

Analysis of operability parameter changes in neoadjuvant treatment with chemotherapy and anti-PD-1/PD-L1.

Analysis of operability parameter changes in neoadjuvant treatment with chemotherapy and anti-PD-1/PD-L1.

Journal: Cancer treatment and research communications
Published: October 07, 2024

BRAF mutational status is associated with survival outcomes in locally advanced resectable and metastatic NSCLC.

BRAF mutational status is associated with survival outcomes in locally advanced resectable and metastatic NSCLC.

Journal: Lung cancer (Amsterdam, Netherlands)
Published: February 19, 2024

Immunogenicity of COVID-19 vaccines in lung cancer patients.

Immunogenicity of COVID-19 vaccines in lung cancer patients.

Journal: Lung cancer (Amsterdam, Netherlands)
Published: July 21, 2023

Olaparib maintenance versus placebo in platinum-sensitive non-small cell lung cancer: the Phase 2 randomized PIPSeN trial.

Olaparib maintenance versus placebo in platinum-sensitive non-small cell lung cancer: the Phase 2 randomized PIPSeN trial.

Journal: British journal of cancer
Published: April 29, 2023

Long-term Clinical Outcomes of a Spanish Cohort of Metastatic Renal Cell Carcinoma Patients with a Complete Response to Sunitinib.

Long-term Clinical Outcomes of a Spanish Cohort of Metastatic Renal Cell Carcinoma Patients with a Complete Response to Sunitinib.

Journal: Clinical genitourinary cancer
Published: October 10, 2022

Assessment of exposure-response relationship for cetuximab in patients with metastatic colorectal cancer and head and neck cancer.

Assessment of exposure-response relationship for cetuximab in patients with metastatic colorectal cancer and head and neck cancer.

Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
Published: April 05, 2022

A Multicenter Analysis of the Outcome of Cancer Patients with Neutropenia and COVID-19 Optionally Treated with Granulocyte-Colony Stimulating Factor (G-CSF): A Comparative Analysis.

A Multicenter Analysis of the Outcome of Cancer Patients with Neutropenia and COVID-19 Optionally Treated with Granulocyte-Colony Stimulating Factor (G-CSF): A Comparative Analysis.

Journal: Cancers
Published: July 08, 2021

Seroprevalence and immunological memory against SARS-CoV-2 in lung cancer patients: the SOLID study.

Seroprevalence and immunological memory against SARS-CoV-2 in lung cancer patients: the SOLID study.

Journal: Translational lung cancer research
Published: June 20, 2021
Showing 1-12 of 19

Last Updated: 09/26/2026